Navigation Links
WaferGen Announces Delay in Reporting of Second Quarter 2011 Results
Date:8/23/2011

FREMONT, Calif., Aug. 23, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, announced today that it intends to file its Quarterly Report on Form 10-Q for the period ended June 30, 2011 within two weeks.  The company had previously filed a Form 12b-25 with the Securities and Exchange Commission relating to its Form 10-Q filing.  

In order to complete its financial statements and other information contained in the Quarterly Report on Form 10-Q, the company needs additional time to finalize the valuation amounts and related accounting treatment of convertible preferred stock, convertible notes and warrants issued on May 27, 2011 in the company's $30.6 million private placement financing.  

About WaferGen Biosystems, Inc. 

WaferGen Biosystems, Inc. develops, manufactures and sells state-of-the-art systems for genomic analysis for the life science and pharmaceutical industries to advance next generation sequencing and ultimately personalized medicine.  WaferGen offers the breakthrough SmartChip Real-Time PCR System, a next-generation Real-Time PCR system for discovery and validation of gene expression patterns (biomarkers) on a single platform. For additional information, please see http://www.wafergen.com.

Forward Looking Statements

This press release contains certain "forward-looking statements" relating to the expected filing date of the company's Form 10-Q for the second quarter of 2011.  Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of the company.  Actual results may differ materially from the expectations contained in the forward-looking statements.   More detailed information about t
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. WaferGen Announces Second Quarter 2008 Financial Results
2. WaferGen to Present at the Seventh Annual BIO Investor Forum
3. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
4. WaferGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
5. WaferGen Announces Third Quarter 2008 Financial Results
6. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
7. Data on WaferGens SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference
8. Data on WaferGens SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference
9. WaferGen to Present Data on SmartChip(TM) Real-Time PCR System at Cambridge Healthtech Institutes Quantitative PCR Conference
10. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
11. WaferGen Announces Signing of Private Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Quincy Bioscience, ... and development of calcium-binding proteins to support healthy ... safety assessment study of apoaequorin in ... published for the British Industrial Biological Research Association. ... to investigate potential adverse effects, if any, of ...
(Date:5/23/2013)... Can economic incentives such as gift cards, T-shirts, ... public to increase their donations of blood? , A ... School Assistant Professor Mario Macis says the answer ... of recent research that supports their argument, the three ... Science that the World Health Organization and national blood ...
(Date:5/23/2013)... The maker community is a contemporary ... They focus on learning practical skills while applying them ... bringing their ideas to life via crowdfunding. A subgroup ... making projects using biology. Glowing Plant has worked for ... them glow with bioluminescence genes, and has now pursued ...
(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...
Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
... Heritage Labs, a,division of Hooper Holmes (Amex: ... a new at-home consumer product that measures the ... The Appraise(R) Home,A1c Kit provides consumers with an ... and reliable test results equivalent to whole,blood tests ...
... YORK, Aug. 7 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ... 11, 2008,at 8:30 a.m. EDT to discuss the second ... Executive Officer of the Company, will,host the call. Keryx ... press release to be issued prior to the call., ...
... (OTC Bulletin Board: GNTA) today announced financial results,for the ... in the second quarter, including the following:, -- ... -- AGENDA Phase 3 trial of Genasense in ... tesetaxel, a leading, clinical-stage oral taxane,lifted by FDA, ...
Cached Biology Technology:Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 2Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 3Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 4Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT 2Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 2Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 3Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 4Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 5Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 6Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 7Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 8Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 9Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 10
(Date:5/23/2013)... mechanism by which estrogen suppresses lipid synthesis in the ... approach toward treating certain liver diseases. , With ... are changing long-held views in the field. Study results ... Science Signaling . , "The dogma in the ... only receptors located in the nucleus respond to steroid ...
(Date:5/23/2013)... Given the implications for the overall health, development, ... a primary role in ensuring that all students ... minutes per day of vigorous or moderate-intensity physical ... of Medicine. Recent estimates suggest that only ... guideline for promoting better health and development. ...
(Date:5/23/2013)... 2013) A new report from the Institute of ... engage in at least 60 minutes of vigorous or ... more than half of American youth meet current evidence-based ... moderate intensity physical activity daily, according to the report, ... in school for nearly half of their waking hours, ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3Schools should provide students with daily physical activity, IOM recommends 2
... 5, 2007) As if being admitted to the ... higher risk of becoming infected with a superbug bacterium, ... difficile kill human intestinal cells by causing them to ... fuel. This results in severe diarrhea and, in rare ...
... dog-walking in bushland significantly reduces bird diversity and ... practice in sensitive bushland and conservation areas. ... impacts of dog-walking have remained subjective and unresolved ... the first clear evidence that birds perceive dogs ...
... know. The supermarket headlines tell us so., Inquiring Texas ... B a tiny, sometimes obscure pest that can damage ... to young cotton for about four weeks," said Dr. ... Lubbock. "They feed on new plant growth, primarily the ...
Cached Biology News:Curbing C. difficile's toxin production 2A dog in the hand scares birds in the bush 2Inquiring minds want to know about cotton fleahoppers 2Inquiring minds want to know about cotton fleahoppers 3
... simple and convenient method for the rapid, thorough ... optimized for use with S. cerevisiae and C. ... species that is susceptible to yeast lytic enzyme ... of yeast cells that are ideal for both ...
... pump series combines Harvard Apparatuss best pump mechanism, ... wide range of configuration options. A lookup table ... syringes from all the major manufacturers. A bright, ... pertinent information from across the lab. All models ...
... syringe pump series combines Harvard Apparatuss best pump ... a wide range of configuration options. A lookup ... of syringes from all the major manufacturers. A ... the pertinent information from across the lab. All ...
... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ... assistance. Feature: tissue-culture treated yes ... cm 2 D H 60 ...
Biology Products: